Vaxxas receives MMI grant for vaccine patch production
Syringe-free vaccination technology company Vaxxas is to receive an $8.2 million grant to support the scale up of manufacturing at its Australian manufacturing facility. The Cambridge Massachusetts and Australian company was awarded the second round grant as part of the federal government’s Modern Manufacturing Initiative (MMI) to support manufacture of its skin patch which delivers…
Details










